Beacon Investment Advisory Services Inc. held its position in shares of Perrigo Company (NYSE:PRGO) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,000 shares of the company’s stock at the end of the second quarter. Beacon Investment Advisory Services Inc.’s holdings in Perrigo were worth $302,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in PRGO. Credit Suisse AG boosted its position in shares of Perrigo by 13.8% in the first quarter. Credit Suisse AG now owns 241,688 shares of the company’s stock worth $16,046,000 after buying an additional 29,375 shares in the last quarter. State of New Jersey Common Pension Fund D purchased a new position in shares of Perrigo during the first quarter worth $29,876,000. Amalgamated Bank boosted its position in shares of Perrigo by 6.0% in the first quarter. Amalgamated Bank now owns 9,759 shares of the company’s stock worth $648,000 after buying an additional 555 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of Perrigo by 238.6% in the first quarter. BNP Paribas Arbitrage SA now owns 130,252 shares of the company’s stock worth $8,647,000 after buying an additional 91,784 shares in the last quarter. Finally, Teachers Advisors LLC boosted its position in shares of Perrigo by 6.8% in the fourth quarter. Teachers Advisors LLC now owns 175,090 shares of the company’s stock worth $14,573,000 after buying an additional 11,079 shares in the last quarter. 76.30% of the stock is currently owned by institutional investors.

Shares of Perrigo Company (NYSE PRGO) traded down 0.11% during midday trading on Thursday, reaching $79.09. 86,586 shares of the company’s stock traded hands. The company has a 50 day moving average of $73.83 and a 200 day moving average of $73.17. The firm’s market cap is $11.28 billion. Perrigo Company has a 52-week low of $63.68 and a 52-week high of $99.14.

Perrigo (NYSE:PRGO) last issued its earnings results on Thursday, August 10th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $0.94 by $0.28. Perrigo had a negative net margin of 51.04% and a positive return on equity of 11.55%. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.18 billion. During the same period in the previous year, the firm earned $1.93 earnings per share. The firm’s revenue for the quarter was down 7.7% on a year-over-year basis. On average, equities analysts predict that Perrigo Company will post $4.52 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 25th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.81%. The ex-dividend date of this dividend is Wednesday, August 23rd. Perrigo’s payout ratio is -3.51%.

WARNING: This story was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/08/17/beacon-investment-advisory-services-inc-has-302000-stake-in-perrigo-company-prgo.html.

Several research firms recently commented on PRGO. Deutsche Bank AG cut their price objective on shares of Perrigo from $87.00 to $86.00 and set a “buy” rating on the stock in a research report on Wednesday, April 19th. B. Riley reaffirmed a “neutral” rating and issued a $67.00 price objective on shares of Perrigo in a research report on Saturday, April 22nd. Jefferies Group LLC reaffirmed a “hold” rating and issued a $71.00 price objective on shares of Perrigo in a research report on Wednesday, May 24th. Royal Bank Of Canada boosted their price objective on shares of Perrigo from $60.00 to $64.00 and gave the company an “underperform” rating in a research report on Friday, August 11th. Finally, Goldman Sachs Group, Inc. (The) reaffirmed a “sell” rating and issued a $68.00 price objective on shares of Perrigo in a research report on Wednesday, May 31st. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have issued a buy rating to the company’s stock. Perrigo presently has a consensus rating of “Hold” and a consensus target price of $86.83.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company (NYSE:PRGO).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Stock Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related stocks with our FREE daily email newsletter.